Aurora Cannabis (TSE:ACB) Hits New 52-Week Low – Here’s Why

Aurora Cannabis Inc. (TSE:ACBGet Free Report)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as C$3.74 and last traded at C$3.76, with a volume of 313521 shares. The stock had previously closed at C$3.86.

Analysts Set New Price Targets

ACB has been the subject of several analyst reports. Canaccord Genuity Group decreased their price objective on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. TD reduced their price target on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of C$7.17.

Check Out Our Latest Stock Report on Aurora Cannabis

Aurora Cannabis Stock Performance

The company has a quick ratio of 2.48, a current ratio of 5.94 and a debt-to-equity ratio of 4.66. The stock’s fifty day moving average is C$4.44 and its two-hundred day moving average is C$4.92. The firm has a market capitalization of C$232.90 million, a price-to-earnings ratio of -1.76 and a beta of 0.27.

Aurora Cannabis (TSE:ACBGet Free Report) last announced its quarterly earnings results on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. The firm had revenue of C$38.01 million during the quarter. On average, analysts predict that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

See Also

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.